Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 59 % of short-term debt in 2025; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2022.
Financials
Financial year 2025
APOTHEEK SCHEPENS from Tongeren-Borgloon, company number BE0771512462, closed financial year 2025 with a result of € 44,892 after tax. For that financial year APOTHEEK SCHEPENS recorded a gross margin of € 194,590 and equity of € 49,891. Compared with financial year 2024, the result moved from € 52,032 to € 44,892. The company is profitable. The buffer shrank hard: equity is 64 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.
€ 49,891
▼ 64% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today. At incorporation the founders contributed € 1 in kind: shares or other assets, valued in the deed.
€ 44,892
▼ 14% vs 2024
Profit after tax over the fiscal year.
€ 33,060
▲ 71% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 132,997 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
1.3
Average over the fiscal year, from the social balance sheet.
€ 89,511
▲ 6% vs 2024
€ 68,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,247
▼ 40% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 214,035
▼ 19% vs 2024
€ 115,671 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 80,841
▲ 23% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 23,672
▲ 22% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 180,584 | € 160,074 | € 200,858 | € 194,590 | ▼ 3% |
| Profit after taxes | € 49,094 | € 16,209 | € 52,032 | € 44,892 | ▼ 14% |
| Equity | € 69,755 | € 85,964 | € 137,996 | € 49,891 | ▼ 64% |
| Total debts | € 432,727 | € 386,712 | € 353,346 | € 398,627 | ▲ 13% |
| Cash | € 27,708 | € 16,892 | € 19,289 | € 33,060 | ▲ 71% |
| Retained profit | € 64,756 | € 80,965 | € 132,997 | € 44,892 | ▼ 66% |
| Dividend | € 0 | € 0 | € 0 | € 132,997 | |
| Bank debt | € 366,644 | € 313,766 | € 262,918 | € 214,035 | ▼ 19% |
| Balance sheet total | € 502,482 | € 472,676 | € 491,341 | € 448,518 | ▼ 9% |
| Employees (FTE) | 1.2 | 1.3 | 1.3 | 1.3 |
By gross margin, APOTHEEK SCHEPENS ranks 6th of 15 companies with main activity “Detailhandel in farmaceutische producten” in Tongeren-Borgloon that publish figures (fiscal year 2025).
Key figures of APOTHEEK SCHEPENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about APOTHEEK SCHEPENS the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to APOTHEEK SCHEPENS?
What happened at APOTHEEK SCHEPENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 44,892 (▼ 14% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Tongeren-Borgloon. KBO
In short
From € 49,094 profit in 2022 to € 44,892 profit in 2025.
Paid € 47,033 in corporate taxes since 2022.
Best year ever: 2024, with € 52,032 profit.
On average € 149,700 of value added per employee in 2025.
Management
Behind APOTHEEK SCHEPENS is An Sofie Elisabeth Schepens.
Directors
According to the 2025 annual accounts
An Sofie Elisabeth Schepens
Director
Establishments
Establishment units
Physical locations of this company
Kruissteenweg 7
3700 Tongeren-Borgloon
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Tongeren-Borgloon
Same main activity (Detailhandel in farmaceutische producten), 15 active companies in Tongeren-Borgloon, largest first.
€ 1.1 million gross margin · 2025
€ 419,595 gross margin · 2025
€ 245,230 gross margin · 2025
€ 210,617 gross margin · 2025
€ 195,028 gross margin · 2025
€ 190,250 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- SCHEPENS An Sofie Elisabeth(oprichter) 100%
Details
- Company number
- 0771.512.462
- VAT number
- BE 0771.512.462
- Registered office
- Kruissteenweg 7, 3700 Tongeren-Borgloon
- Names & denominations
- APOTHEEK SCHEPENS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 July 2021
- Peppol
- Active · Active since 9 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Vervaardiging van geneesmiddelen